RNA polymerase variants
Engineered RNA polymerase variants address the challenges of low yield and fidelity by improving activity and thermostability, resulting in enhanced RNA production efficiency and reduced undesirable products, making them more effective for therapeutic and analytical uses.
Patent Information
- Application Number
- PCT/US2024/028884
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-21
AI Technical Summary
Current RNA polymerases face challenges in producing RNA with high yield and fidelity, often resulting in undesirable products such as incomplete transcripts and double-stranded RNA, which limits their effectiveness in therapeutic and analytical applications.
Engineered RNA polymerase variants with specific amino acid sequences, exhibiting increased activity, thermostability, and improved co-capping capabilities, are developed to enhance RNA production efficiency and yield.
The engineered RNA polymerases demonstrate improved RNA production with increased yield and fidelity, reducing the formation of undesirable products and enhancing their suitability for therapeutic and analytical applications.
Smart Images

Figure IMGF000009_0001 
Figure IMGF000027_0001 
Figure IMGF000127_0001
Abstract
Citation Information
Patent Citations
Polypeptides derived from rna polymerases and use thereof
US20040091854A1
T7 RNA polymerase variants
US20190002851A1
T7 RNA polymerase variants
US20200354699A1
RNA polymerase variants for co-transcriptional capping
WO2020172239A1
